ID,MEDICATION,GENE(S),PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST,INTERACTION
K76-155-RT,Amitriptyline (Gpc-Amitriptyline),"CYP2C19CYP2D6",Major – significant result that may require altering this medication,INCREASED RISK OF SEROTONIN TOXICITY WITH AMITRIPTYLINE AND DESVENLAFAXINE
K76-155-RT,Rabeprazole,CYP2C19,"Minor – result should be considered as may affect medicationresponse",NA
K76-155-RT,Ondansetron,CYP2D6,Usual prescribing considerations apply,INCREASED RISK OF SEROTONIN TOXICITY WITH AMITRIPTYLINE AND DESVENLAFAXINE
K76-155-RT,desvenlafaxine,NO,NA,INCREASED RISK OF SEROTONIN TOXICITY WITH AMITRIPTYLINE AND ONDANSETRON
K76-155-RT, bupropion,NO,NA,INHIBITOR STRONG: CYP2D6
K76-155-RT, spironolactone,NO,NA,NA
K76-155-RT, travoprost,NO,NA,NA
